nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A3—Metformin—metabolic syndrome X	0.36	0.475	CbGbCtD
Norepinephrine—SLC22A2—Metformin—metabolic syndrome X	0.213	0.281	CbGbCtD
Norepinephrine—SLC22A1—Metformin—metabolic syndrome X	0.185	0.244	CbGbCtD
Norepinephrine—ADRB3—brown adipose tissue—metabolic syndrome X	0.0269	0.306	CbGeAlD
Norepinephrine—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.0108	0.123	CbGeAlD
Norepinephrine—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00725	0.0826	CbGeAlD
Norepinephrine—PAH—kidney—metabolic syndrome X	0.00515	0.0586	CbGeAlD
Norepinephrine—ADRB3—adipose tissue—metabolic syndrome X	0.00362	0.0413	CbGeAlD
Norepinephrine—PAH—liver—metabolic syndrome X	0.00325	0.0371	CbGeAlD
Norepinephrine—SLC22A2—kidney—metabolic syndrome X	0.00242	0.0275	CbGeAlD
Norepinephrine—ADRA1B—kidney—metabolic syndrome X	0.00231	0.0264	CbGeAlD
Norepinephrine—SLC18A2—adipose tissue—metabolic syndrome X	0.00207	0.0235	CbGeAlD
Norepinephrine—SLC22A1—kidney—metabolic syndrome X	0.00171	0.0194	CbGeAlD
Norepinephrine—ADRB1—cardiovascular system—metabolic syndrome X	0.00168	0.0191	CbGeAlD
Norepinephrine—SLC22A3—kidney—metabolic syndrome X	0.00163	0.0186	CbGeAlD
Norepinephrine—SLC22A1—adipose tissue—metabolic syndrome X	0.00154	0.0175	CbGeAlD
Norepinephrine—ADRB1—adipose tissue—metabolic syndrome X	0.00148	0.0169	CbGeAlD
Norepinephrine—SLC22A3—adipose tissue—metabolic syndrome X	0.00147	0.0167	CbGeAlD
Norepinephrine—SLC18A2—liver—metabolic syndrome X	0.00145	0.0165	CbGeAlD
Norepinephrine—ADRA1A—cardiovascular system—metabolic syndrome X	0.00133	0.0151	CbGeAlD
Norepinephrine—ADRA2C—kidney—metabolic syndrome X	0.00124	0.0141	CbGeAlD
Norepinephrine—SLC22A5—kidney—metabolic syndrome X	0.00119	0.0135	CbGeAlD
Norepinephrine—ADRA1A—adipose tissue—metabolic syndrome X	0.00117	0.0133	CbGeAlD
Norepinephrine—ADRA2C—adipose tissue—metabolic syndrome X	0.00112	0.0127	CbGeAlD
Norepinephrine—SLC22A1—liver—metabolic syndrome X	0.00108	0.0123	CbGeAlD
Norepinephrine—SLC22A5—adipose tissue—metabolic syndrome X	0.00107	0.0122	CbGeAlD
Norepinephrine—SLC22A3—liver—metabolic syndrome X	0.00103	0.0117	CbGeAlD
Norepinephrine—ADRA2A—adipose tissue—metabolic syndrome X	0.000891	0.0101	CbGeAlD
Norepinephrine—ADRA1A—liver—metabolic syndrome X	0.000822	0.00936	CbGeAlD
Norepinephrine—ADRA2C—liver—metabolic syndrome X	0.000783	0.00892	CbGeAlD
Norepinephrine—SLC22A5—liver—metabolic syndrome X	0.00075	0.00854	CbGeAlD
Norepinephrine—CYP1A2—liver—metabolic syndrome X	0.000679	0.00774	CbGeAlD
Norepinephrine—ADRA2C—Metabolism—AGT—metabolic syndrome X	2.09e-05	0.000137	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL5—metabolic syndrome X	2.09e-05	0.000137	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—APOA1—metabolic syndrome X	2.09e-05	0.000136	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.09e-05	0.000136	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—APOB—metabolic syndrome X	2.08e-05	0.000136	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AGT—metabolic syndrome X	2.08e-05	0.000135	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PPARA—metabolic syndrome X	2.07e-05	0.000135	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.07e-05	0.000135	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL5—metabolic syndrome X	2.06e-05	0.000134	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.05e-05	0.000134	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—APOE—metabolic syndrome X	2.05e-05	0.000134	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—LPL—metabolic syndrome X	2.05e-05	0.000134	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.04e-05	0.000133	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TGFB1—metabolic syndrome X	2.04e-05	0.000133	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—LEP—metabolic syndrome X	2.03e-05	0.000133	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—APOE—metabolic syndrome X	2.03e-05	0.000133	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—APOA1—metabolic syndrome X	2.03e-05	0.000132	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PLA2G4A—metabolic syndrome X	2.03e-05	0.000132	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	2.02e-05	0.000132	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—LPL—metabolic syndrome X	2.01e-05	0.000131	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—APOA1—metabolic syndrome X	2.01e-05	0.000131	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AGT—metabolic syndrome X	2.01e-05	0.000131	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—AKT1—metabolic syndrome X	2.01e-05	0.000131	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IGF2—metabolic syndrome X	2e-05	0.000131	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—LPL—metabolic syndrome X	1.99e-05	0.00013	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CCL2—metabolic syndrome X	1.98e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—IL6—metabolic syndrome X	1.97e-05	0.000129	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—APOE—metabolic syndrome X	1.97e-05	0.000128	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOB—metabolic syndrome X	1.95e-05	0.000127	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—APOA1—metabolic syndrome X	1.94e-05	0.000127	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IGF2—metabolic syndrome X	1.93e-05	0.000126	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL5—metabolic syndrome X	1.9e-05	0.000124	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.89e-05	0.000123	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AGT—metabolic syndrome X	1.89e-05	0.000123	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CD36—metabolic syndrome X	1.89e-05	0.000123	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AGT—metabolic syndrome X	1.87e-05	0.000122	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOB—metabolic syndrome X	1.87e-05	0.000122	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—AKT1—metabolic syndrome X	1.87e-05	0.000122	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—LPL—metabolic syndrome X	1.86e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—APOE—metabolic syndrome X	1.85e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—LEP—metabolic syndrome X	1.85e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AGT—metabolic syndrome X	1.85e-05	0.000121	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PPARG—metabolic syndrome X	1.84e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—LEP—metabolic syndrome X	1.84e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—APOE—metabolic syndrome X	1.84e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—APOA1—metabolic syndrome X	1.83e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL5—metabolic syndrome X	1.83e-05	0.000119	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.82e-05	0.000119	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—AKT1—metabolic syndrome X	1.82e-05	0.000119	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—APOA1—metabolic syndrome X	1.82e-05	0.000118	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IRS1—metabolic syndrome X	1.81e-05	0.000118	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—LEP—metabolic syndrome X	1.81e-05	0.000118	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—APOE—metabolic syndrome X	1.81e-05	0.000118	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	1.81e-05	0.000118	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—INS—metabolic syndrome X	1.8e-05	0.000118	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.8e-05	0.000117	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GCK—metabolic syndrome X	1.8e-05	0.000117	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—LIPC—metabolic syndrome X	1.8e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	1.79e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—APOA1—metabolic syndrome X	1.79e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—LPL—metabolic syndrome X	1.79e-05	0.000117	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOC3—metabolic syndrome X	1.79e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PPARG—metabolic syndrome X	1.79e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PPARA—metabolic syndrome X	1.76e-05	0.000115	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—INS—metabolic syndrome X	1.75e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AGT—metabolic syndrome X	1.75e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—AKT1—metabolic syndrome X	1.74e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	1.74e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—INS—metabolic syndrome X	1.74e-05	0.000113	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CETP—metabolic syndrome X	1.74e-05	0.000113	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AGT—metabolic syndrome X	1.72e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—APOE—metabolic syndrome X	1.72e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—LEP—metabolic syndrome X	1.72e-05	0.000112	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PPARG—metabolic syndrome X	1.71e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCL2—metabolic syndrome X	1.71e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AGT—metabolic syndrome X	1.7e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	1.7e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—APOA1—metabolic syndrome X	1.7e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.69e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—LEP—metabolic syndrome X	1.69e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—APOE—metabolic syndrome X	1.69e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IGF1—metabolic syndrome X	1.68e-05	0.00011	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—INS—metabolic syndrome X	1.68e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—APOA1—metabolic syndrome X	1.67e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—APOE—metabolic syndrome X	1.67e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	1.66e-05	0.000108	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	1.66e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IRS1—metabolic syndrome X	1.65e-05	0.000108	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ALB—metabolic syndrome X	1.65e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—APOA1—metabolic syndrome X	1.65e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IRS1—metabolic syndrome X	1.64e-05	0.000107	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.62e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IRS1—metabolic syndrome X	1.62e-05	0.000106	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	1.61e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ALB—metabolic syndrome X	1.61e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SERPINE1—metabolic syndrome X	1.6e-05	0.000104	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AGT—metabolic syndrome X	1.59e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—INS—metabolic syndrome X	1.58e-05	0.000103	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—NOS3—metabolic syndrome X	1.58e-05	0.000103	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GOT2—metabolic syndrome X	1.57e-05	0.000102	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	1.57e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—INS—metabolic syndrome X	1.57e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCL2—metabolic syndrome X	1.56e-05	0.000102	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—LEP—metabolic syndrome X	1.56e-05	0.000102	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOE—metabolic syndrome X	1.56e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—INS—metabolic syndrome X	1.55e-05	0.000101	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TGFB1—metabolic syndrome X	1.55e-05	0.000101	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	1.54e-05	0.000101	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ALB—metabolic syndrome X	1.54e-05	0.0001	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	1.54e-05	0.0001	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—NOS3—metabolic syndrome X	1.54e-05	0.0001	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IGF1—metabolic syndrome X	1.53e-05	9.99e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.53e-05	9.99e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	1.53e-05	9.99e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	1.52e-05	9.95e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NOS3—metabolic syndrome X	1.52e-05	9.95e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	1.52e-05	9.9e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	1.51e-05	9.83e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.5e-05	9.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.5e-05	9.79e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	1.5e-05	9.78e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.48e-05	9.67e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—NOS3—metabolic syndrome X	1.47e-05	9.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	1.47e-05	9.56e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.45e-05	9.49e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.45e-05	9.47e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PTGS2—metabolic syndrome X	1.45e-05	9.43e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	1.44e-05	9.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	1.44e-05	9.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.44e-05	9.4e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—INS—metabolic syndrome X	1.42e-05	9.29e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.42e-05	9.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.42e-05	9.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	1.42e-05	9.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	1.42e-05	9.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.42e-05	9.24e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.42e-05	9.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	1.41e-05	9.17e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.4e-05	9.13e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.4e-05	9.13e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	1.4e-05	9.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.39e-05	9.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.39e-05	9.09e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.39e-05	9.06e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	1.39e-05	9.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.38e-05	8.99e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	1.38e-05	8.98e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	1.36e-05	8.86e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.35e-05	8.84e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.35e-05	8.84e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PTGS2—metabolic syndrome X	1.35e-05	8.79e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.35e-05	8.78e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.34e-05	8.73e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.33e-05	8.68e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.33e-05	8.65e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.31e-05	8.54e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.31e-05	8.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.31e-05	8.52e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.29e-05	8.39e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	1.29e-05	8.39e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	1.29e-05	8.39e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.28e-05	8.36e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	1.27e-05	8.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.26e-05	8.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.25e-05	8.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.24e-05	8.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.24e-05	8.09e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.22e-05	7.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	1.19e-05	7.77e-05	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.19e-05	7.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.19e-05	7.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.18e-05	7.69e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.18e-05	7.68e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	1.17e-05	7.64e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	1.17e-05	7.64e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	1.17e-05	7.61e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL6—metabolic syndrome X	1.17e-05	7.61e-05	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	1.16e-05	7.6e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	1.16e-05	7.57e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—AKT1—metabolic syndrome X	1.16e-05	7.56e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	1.15e-05	7.51e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOB—metabolic syndrome X	1.15e-05	7.5e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	1.15e-05	7.48e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	1.14e-05	7.45e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	1.12e-05	7.33e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	1.12e-05	7.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	1.1e-05	7.19e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—LPL—metabolic syndrome X	1.1e-05	7.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.09e-05	7.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	1.08e-05	7.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.08e-05	7.07e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	1.08e-05	7.05e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—metabolic syndrome X	1.08e-05	7.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	1.07e-05	6.99e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	1.07e-05	6.96e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	1.06e-05	6.9e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	1.04e-05	6.81e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CD36—metabolic syndrome X	1.04e-05	6.8e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	1.01e-05	6.58e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	1e-05	6.53e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	9.99e-06	6.52e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	9.84e-06	6.42e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	9.84e-06	6.42e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	9.7e-06	6.33e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.63e-06	6.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	9.48e-06	6.18e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AGT—metabolic syndrome X	9.39e-06	6.13e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOE—metabolic syndrome X	9.2e-06	6e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	9.18e-06	5.99e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	9.1e-06	5.94e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	9.1e-06	5.93e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	9.08e-06	5.92e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	8.98e-06	5.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.95e-06	5.84e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	8.81e-06	5.75e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	8.74e-06	5.71e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	8.5e-06	5.55e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	8.37e-06	5.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	8.12e-06	5.3e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	8.01e-06	5.23e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—INS—metabolic syndrome X	7.86e-06	5.13e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	7.71e-06	5.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	7.59e-06	4.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	7.43e-06	4.85e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—metabolic syndrome X	7.27e-06	4.74e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—metabolic syndrome X	7.21e-06	4.7e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—metabolic syndrome X	7.07e-06	4.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	7.01e-06	4.57e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	6.92e-06	4.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.9e-06	4.5e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	6.89e-06	4.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	6.86e-06	4.47e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—metabolic syndrome X	6.77e-06	4.42e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	6.77e-06	4.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	6.4e-06	4.18e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	6.38e-06	4.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	6.33e-06	4.13e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	6.3e-06	4.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	6.3e-06	4.11e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	6.24e-06	4.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	5.91e-06	3.86e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	5.82e-06	3.79e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	5.81e-06	3.79e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	5.74e-06	3.75e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	5.6e-06	3.65e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	5.36e-06	3.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	5.2e-06	3.39e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	5.17e-06	3.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	4.8e-06	3.13e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	3.17e-06	2.07e-05	CbGpPWpGaD
